Showing results (311-320 of 2,733) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|April 3, 2012
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatmentsDavid Della-Morte, Fiorella Guadagni, Raffaele Palmirotta, et al.Pharmacogenomics|April 3, 2012
Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancerAkinobu Hamada, Ji-Ichiro Sasaki, Sho Saeki, et al.Pharmacogenomics|November 29, 2011
Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversityCollet Dandara, Zané Lombard, Ingrid Du Plooy, et al.Pharmacogenomics|June 9, 2012
Impact of the UGT1A1*28 allele on response to irinotecan: a systematic review and meta-analysisMafalda M Dias, Ross A McKinnon, Michael J SorichPharmacogenomics|June 9, 2012
Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacyShanna K O'Connor, Stefanie P Ferreri, Natasha M Michaels, et al.Pharmacogenomics|November 23, 2012
Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs studySergi Mas, Adrián Llerena, Jerónimo Saíz, et al.Pharmacogenomics|August 13, 2013
Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam StudyCatherine E de Keyser, Matthijs L Becker, André G Uitterlinden, et al.Pharmacogenomics|August 13, 2013
Pharmacogenetics of olanzapine metabolismMao Mao Söderberg, Marja-Liisa DahlPharmacogenomics|July 27, 2011
Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working groupScott D Patterson, Nadine Cohen, Maha Karnoub, et al.Pharmacogenomics|July 27, 2011
Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complicationsAmy K Lee, Jeffrey R BishopPageof 274